Mammary Neoplasms, Experimental
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Allelic imbalance and altered expression of genes in chromosome 2q11-2q16 from rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
|
12606953 |
2003 |
Mammary Neoplasms, Experimental
|
0.500 |
Biomarker
|
phenotype |
RGD |
Allelic imbalance and altered expression of genes in chromosome 2q11-2q16 from rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
|
12606953 |
2003 |
Malignant neoplasm of prostate
|
0.320 |
Biomarker
|
disease |
CTD_human |
Identification of recurrent fusion genes across multiple cancer types.
|
30705370 |
2019 |
Malignant neoplasm of prostate
|
0.320 |
Biomarker
|
disease |
BEFREE |
We aimed to investigate the association between genetic variants of the DNA repair genes XPG, CSB, XPC, CCNH, and MMS19L in the nucleotide excision repair (NER) pathway and risk of prostate cancer in a population in China.
|
24615090 |
2014 |
Malignant neoplasm of prostate
|
0.320 |
Biomarker
|
disease |
BEFREE |
We assessed the association between genetic variants of XPG, XPA, XPD, CSB, XPC and CCNH in the nucleotide excision repair (NER) pathway and risk of prostate cancer.
|
24289586 |
2013 |
Malignant neoplasm of breast
|
0.310 |
Biomarker
|
disease |
CTD_human |
Among them, the CCNH-C5orf30 and TRMT11-GRIK2 gene fusions were found in breast cancer, colon cancer, non-small cell lung cancer, esophageal adenocarcinoma, glioblastoma multiforme, ovarian cancer and liver cancer, with frequencies ranging from 12.9% to 85%.
|
30705370 |
2019 |
Malignant tumor of colon
|
0.310 |
Biomarker
|
disease |
CTD_human |
Among them, the CCNH-C5orf30 and TRMT11-GRIK2 gene fusions were found in breast cancer, colon cancer, non-small cell lung cancer, esophageal adenocarcinoma, glioblastoma multiforme, ovarian cancer and liver cancer, with frequencies ranging from 12.9% to 85%.
|
30705370 |
2019 |
Breast Carcinoma
|
0.310 |
Biomarker
|
disease |
CTD_human |
Among them, the CCNH-C5orf30 and TRMT11-GRIK2 gene fusions were found in breast cancer, colon cancer, non-small cell lung cancer, esophageal adenocarcinoma, glioblastoma multiforme, ovarian cancer and liver cancer, with frequencies ranging from 12.9% to 85%.
|
30705370 |
2019 |
Mammary Neoplasms
|
0.310 |
Biomarker
|
group |
CTD_human |
Identification of recurrent fusion genes across multiple cancer types.
|
30705370 |
2019 |
Malignant tumor of colon
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Downregulation of LIG4 and PNKP and upregulation of XRCC5 and CCNH DNA-repair-related genes were involved in the radio-sensitizing efficacy of curcumin in colon cancer.
|
29277765 |
2018 |
Malignant neoplasm of breast
|
0.310 |
Biomarker
|
disease |
BEFREE |
Expressions of components of the CAK complex, CDK7, MAT1, and Cyclin H are elevated in breast cancer and correlate with ER.
|
27301701 |
2016 |
Breast Carcinoma
|
0.310 |
Biomarker
|
disease |
BEFREE |
Expressions of components of the CAK complex, CDK7, MAT1, and Cyclin H are elevated in breast cancer and correlate with ER.
|
27301701 |
2016 |
Mammary Neoplasms
|
0.310 |
AlteredExpression
|
group |
BEFREE |
Identification of two isoforms of the Cak receptor kinase that are coexpressed in breast tumor cell lines.
|
8622863 |
1996 |
Non-Small Cell Lung Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Among them, the CCNH-C5orf30 and TRMT11-GRIK2 gene fusions were found in breast cancer, colon cancer, non-small cell lung cancer, esophageal adenocarcinoma, glioblastoma multiforme, ovarian cancer and liver cancer, with frequencies ranging from 12.9% to 85%.
|
30705370 |
2019 |
Colonic Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Identification of recurrent fusion genes across multiple cancer types.
|
30705370 |
2019 |
Esophageal Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Identification of recurrent fusion genes across multiple cancer types.
|
30705370 |
2019 |
Glioblastoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Among them, the CCNH-C5orf30 and TRMT11-GRIK2 gene fusions were found in breast cancer, colon cancer, non-small cell lung cancer, esophageal adenocarcinoma, glioblastoma multiforme, ovarian cancer and liver cancer, with frequencies ranging from 12.9% to 85%.
|
30705370 |
2019 |
Liver neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Identification of recurrent fusion genes across multiple cancer types.
|
30705370 |
2019 |
Lymphatic Metastasis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Identification of recurrent fusion genes across multiple cancer types.
|
30705370 |
2019 |
Prostatic Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Identification of recurrent fusion genes across multiple cancer types.
|
30705370 |
2019 |
Giant Cell Glioblastoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Identification of recurrent fusion genes across multiple cancer types.
|
30705370 |
2019 |
Malignant neoplasm of liver
|
0.300 |
Biomarker
|
disease |
CTD_human |
Among them, the CCNH-C5orf30 and TRMT11-GRIK2 gene fusions were found in breast cancer, colon cancer, non-small cell lung cancer, esophageal adenocarcinoma, glioblastoma multiforme, ovarian cancer and liver cancer, with frequencies ranging from 12.9% to 85%.
|
30705370 |
2019 |
Malignant neoplasm of esophagus
|
0.300 |
Biomarker
|
disease |
CTD_human |
Identification of recurrent fusion genes across multiple cancer types.
|
30705370 |
2019 |
ovarian neoplasm
|
0.300 |
Biomarker
|
disease |
CTD_human |
Among them, the CCNH-C5orf30 and TRMT11-GRIK2 gene fusions were found in breast cancer, colon cancer, non-small cell lung cancer, esophageal adenocarcinoma, glioblastoma multiforme, ovarian cancer and liver cancer, with frequencies ranging from 12.9% to 85%.
|
30705370 |
2019 |
Malignant neoplasm of ovary
|
0.300 |
Biomarker
|
disease |
CTD_human |
Among them, the CCNH-C5orf30 and TRMT11-GRIK2 gene fusions were found in breast cancer, colon cancer, non-small cell lung cancer, esophageal adenocarcinoma, glioblastoma multiforme, ovarian cancer and liver cancer, with frequencies ranging from 12.9% to 85%.
|
30705370 |
2019 |